Can we define a tolerable level of risk in food allergy? Report from a EuroPrevall/UK Food Standards Agency workshop

被引:47
作者
Madsen, C. B. [1 ]
Hattersley, S. [2 ]
Allen, K. J. [3 ]
Beyer, K. [4 ]
Chan, C. -H. [2 ]
Godefroy, S. B. [5 ]
Hodgson, R. [2 ]
Mills, E. N. C. [6 ]
Munoz-Furlong, A. [7 ]
Schnadt, S. [8 ]
Ward, R. [9 ]
Wickman, M. [10 ,11 ]
Crevel, R. [12 ]
机构
[1] Tech Univ Denmark, Dept Toxicol & Risk Assessment, Natl Food Inst, DK-2860 Soborg, Denmark
[2] Food Stand Agcy, Food Allergy Branch, London, England
[3] Univ Melbourne, Royal Childrens Hosp, Dept Paediat, Murdoch Childrens Res Inst, Melbourne, Vic, Australia
[4] Charite, Med Ctr, Dept Paediat Pneumol & Immunol, Berlin, Germany
[5] Hlth Canada, Food Directorate, Ottawa, ON, Canada
[6] AFRC, Inst Food Res, Norwich NR4 7UA, Norfolk, England
[7] Food Allergy & Anaphylaxis Network, Fairfax, VA USA
[8] Deutscher Allergie & Asthmabund, Monchengladbach, Germany
[9] PepsiCo Int, Leicester, Leics, England
[10] Karolinska Inst, Sachs Childrens Hosp, Stockholm, Sweden
[11] Karolinska Inst, Inst Environm Med, S-10401 Stockholm, Sweden
[12] Unilever Safety & Environm Assurance Ctr, Bedford, England
关键词
EuroPrevall; food allergy; risk assessment; stakeholders; tolerable risk; UK Food Standards Agency; PEANUT; ANAPHYLAXIS;
D O I
10.1111/j.1365-2222.2011.03868.x
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
Background There is an emerging consensus that, as with other risks in society, zero risk for food-allergic people is not a realistic or attainable option. Food allergy challenge data and new risk assessment methods offer the opportunity to develop quantitative limits for unintended allergenic ingredients which can be used in risk-based approaches. However, a prerequisite to their application is defining a tolerable level of risk. This requires a value judgement and is ultimately a ` societal' decision that has to involve all relevant stakeholders. Objective The aim of the workshop was to bring together key representatives from the stakeholders (regulators, food industry, clinical researchers and patients), and for the first time ever discuss the definition of a tolerable level of risk with regard to allergic reactions to food. Results The discussions revealed a consensus that zero risk was not a realistic option and that it is essential to address the current lack of agreed action levels for cross-contamination with allergens if food allergen management practice is to be improved. The discussions also indicated that it was difficult to define and quantify a tolerable level of risk, although both the clinical and the industry groups tried to do so. A consensus emerged that doing nothing was not a viable option, and there was a strong desire to take action to improve the current situation. Conclusions and Clinical Relevance Two concrete actions were suggested: (1) Action levels should be derived from the data currently available. Different scenarios should be examined and further developed in an iterative process. On the basis of this work, a tolerable level of risk should be proposed. (2) ` One-dose' clinical trial with a low challenge dose should be performed in multiple centres to provide additional information about the general applicability of dose-distribution models and help validate the threshold levels derived.
引用
收藏
页码:30 / 37
页数:8
相关论文
共 22 条
[1]  
[Anonymous], 1984, GUID DRINK WAT QUAL
[2]  
*AUSTR FOOD GROC C, 2007, FOOD IND GUID ALL MA
[3]   Effects of cooking methods on peanut allergenicity [J].
Beyer, KB ;
Morrow, E ;
Li, XM ;
Bardina, L ;
Bannon, GA ;
Burks, AW ;
Sampson, HA .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2001, 107 (06) :1077-1081
[4]   Oral peanut immunotherapy in children with peanut anaphylaxis [J].
Blumchen, Katharina ;
Ulbricht, Helen ;
Staden, Ute ;
Dobberstein, Kerstin ;
Beschorner, John ;
de Oliveira, Lucila Camargo Lopes ;
Shreffler, Wayne G. ;
Sampson, Hugh A. ;
Niggemann, Bodo ;
Wahn, Ulrich ;
Beyer, Kirsten .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2010, 126 (01) :83-91
[5]  
Buchanan R, 2008, J FOOD PROTECT, V71, P1043
[6]   Thresholds for food allergens and their value to different stakeholders [J].
Crevel, R. W. R. ;
Ballmer-Weber, B. K. ;
Holzhauser, T. ;
Hourihane, J. O'B. ;
Knulst, A. C. ;
Mackie, A. R. ;
Timmermans, F. ;
Taylor, S. L. .
ALLERGY, 2008, 63 (05) :597-609
[7]   Management of peanut and nut allergy [J].
Ewan, P ;
Clark, A .
LANCET, 2001, 357 (9262) :1127-1127
[8]   Does severity of low-dose, double-blind, placebo-controlled food challenges reflect severity of allergic reactions to peanut in the community? [J].
Hourihane, JO ;
Grimshaw, KEC ;
Lewis, SA ;
Briggs, RA ;
Trewin, JB ;
King, RM ;
Kilburn, SA ;
Warner, JO .
CLINICAL AND EXPERIMENTAL ALLERGY, 2005, 35 (09) :1227-1233
[9]  
Hunter P., 2001, WATER QUALITY GUIDEL, P207
[10]   Food-induced anaphylaxis [J].
Jaervinen, Kirsi M. .
CURRENT OPINION IN ALLERGY AND CLINICAL IMMUNOLOGY, 2011, 11 (03) :255-261